Eli Lilly's (LLY) stock surges 14% as its diabetes drug orforglipron meets Phase 3 goals, cutting weight by 8%. Read more ...

Medicare Part D prescription drug plans and Medicare Advantage plans with prescription drug coverage cover various diabetes-related costs, including Trulicity. Out-of-pocket costs may apply.

Bernstein's Diabetes Diet is a very low-carbohydrate diet designed ... on new technology (such as insulin pumps and continuous blood sugar monitors), medications (including inhaled insulin), and ...

Semaglutide, the diabetes and weight loss drug that’s commonly known as Ozempic, can help patients of peripheral artery disease (a circulatory problem where narrowed arteries reduce blood flow to the ...

You can discuss your diabetes management and care plan with your healthcare team, letting them know if a particular medication or care plan isn’t working as well as you’d like. This can help ...

Unfortunately, rather than addressing the fundamental lifestyle factors that contribute to Type 2 diabetes, patients and providers have become increasingly reliant on medications that slow the ...

Researchers have launched a phase 1/2 clinical trial to see if osteoporosis medication can enhance beta cell health among people living with early type 1 diabetes. During the trial, scientists from ...

Depending on the type of diabetes, medication may be required to manage blood sugars and to protect the heart, kidney, brain, and other organs affected by diabetes. When it comes to managing ...

Notably, Hsu and colleagues reported that the increased risk for NAION was found only in women with diabetes who received semaglutide vs. those who received a non-GLP-1 RA medication.

In addition, more than two-thirds of older adults have two or more chronic conditions, which may require multiple medications that can add additional burden to diabetes management. Researchers at ATTD ...

Though life-changing medications like semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) are only approved right now for type 2 diabetes, a growing body of evidence shows the potential ...